2-Chloro-6,8-dimethylquinoline-3-carbaldehyde, 95+%, 250mg

8-Fluoro-4-oxo-chroman, 95.0%, 1g

6-Chloro-2-(3,5-dimethoxyphenyl)pyridazin-3(2H)-one, 95.0%, 1g

7-Bromoheptanoic acid, 97.0%, 10g

ETHYL 7-OXO-4,5,6,7-TETRAHYDROBENZOFURAN-6-CARBOXYLATE, 95.0%, 250mg

7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid, 95.0%, 5g

1-Ethoxy-2-(2-methoxyethoxy)ethane, 95.0%, 25g

2-Phenyl-4,5-dihydrooxazole, 95.0%, 500g

Cyclopropylmethyl bromide, 98.0%, 100g

2-pyrazin-2-yl-1,3-thiazole-4-carboxylic acid, 95.0%, 2.5g

(4-Hexylphenyl)boronic acid, 95.0%, 1g

Microliter syringe GASTIGHT® series 1700 Point type 3, 50 µl, 1705 RNR, 1 piece

1,6-Hexanediaminium, N1,N6-bis[3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl]-N1,N1,N6,N6-tetramethyl-, bromide (1:2), 98%, 250mg